A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Clinical trial NCT05912517 · RECRUITING
Trial details
- NCT number
- NCT05912517
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2027-08-05
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.